HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Registry of transcatheter aortic-valve implantation in high-risk patients.

Martine Gilard 1 Hélène Eltchaninoff Bernard Iung 2 Patrick Donzeau-Gouge Karine Chevreul Jean Fajadet Pascal Leprince 3 Alain Leguerrier 4 Michel Lievre 5 Alain Prat Emmanuel Teiger 6 Thierry Lefevre Dominique Himbert 2 Didier Tchetche Didier Carrié 7 Bernard Albat 8 Alain Cribier 9 Gilles Rioufol 10 Arnaud Sudre Didier Blanchard Frederic Collet Pierre dos Santos 11 Nicolas Meneveau Ashok Tirouvanziam 12 Christophe Caussin Philippe Guyon Jacques Boschat 1 Herve Le Breton Frederic Collart Remi Houel Stephane Delpine Geraud Souteyrand Xavier Favereau Patrick Ohlmann Vincent Doisy Gilles Grollier Antoine Gommeaux Jean-Philippe Claudel Francois Bourlon Bernard Bertrand 13 Eric van Belle 14 Marc Laskar 15, 16, 17 Non Renseigné
Abstract : BACKGROUND: Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We report the results of a prospective multicenter study of the French national transcatheter aortic-valve implantation registry, FRANCE 2. METHODS: All TAVIs performed in France, as listed in the FRANCE 2 registry, were prospectively included in the study. The primary end point was death from any cause. RESULTS: A total of 3195 patients were enrolled between January 2010 and October 2011 at 34 centers. The mean (±SD) age was 82.7±7.2 years; 49% of the patients were women. All patients were highly symptomatic and were at high surgical risk for aortic-valve replacement. Edwards SAPIEN and Medtronic CoreValve devices were implanted in 66.9% and 33.1% of patients, respectively. Approaches were either transarterial (transfemoral, 74.6%; subclavian, 5.8%; and other, 1.8%) or transapical (17.8%). The procedural success rate was 96.9%. Rates of death at 30 days and 1 year were 9.7% and 24.0%, respectively. At 1 year, the incidence of stroke was 4.1%, and the incidence of periprosthetic aortic regurgitation was 64.5%. In a multivariate model, a higher logistic risk score on the European System for Cardiac Operative Risk Evaluation (EuroSCORE), New York Heart Association functional class III or IV symptoms, the use of a transapical TAVI approach, and a higher amount of periprosthetic regurgitation were significantly associated with reduced survival. CONCLUSIONS: This prospective registry study reflected real-life TAVI experience in high-risk elderly patients with aortic stenosis, in whom TAVI appeared to be a reasonable option. (Funded by Edwards Lifesciences and Medtronic.).
Complete list of metadata

https://hal.univ-brest.fr/hal-00811695
Contributor : François Guerrero Connect in order to contact the contributor
Submitted on : Thursday, April 11, 2013 - 12:41:48 AM
Last modification on : Wednesday, April 27, 2022 - 4:36:39 AM

Identifiers

Citation

Martine Gilard, Hélène Eltchaninoff, Bernard Iung, Patrick Donzeau-Gouge, Karine Chevreul, et al.. Registry of transcatheter aortic-valve implantation in high-risk patients.. New England Journal of Medicine, Massachusetts Medical Society, 2012, 366 (18), pp.1705-15. ⟨10.1056/NEJMoa1114705⟩. ⟨hal-00811695⟩

Share

Metrics

Record views

834